Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Psychosis during peginterferon-alpha 2a and ribavirin therapy: case report.

Quarantini LC, Cruz SC, Batista-Neves SC, Paraná R, Miranda-Scippa A, Bressan RA.

Braz J Infect Dis. 2006 Dec;10(6):406-7.

PMID:
17420915
2.

Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.

Onyike CU, Bonner JO, Lyketsos CG, Treisman GJ.

Am J Psychiatry. 2004 Mar;161(3):429-35. No abstract available.

PMID:
14992966
3.

Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.

Sockalingam S, Balderson K.

Int Clin Psychopharmacol. 2005 Sep;20(5):289-90.

PMID:
16096520
4.
5.

Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.

Quarantini LC, Bressan RA, Galvão A, Batista-Neves S, Paraná R, Miranda-Scippa A.

Liver Int. 2007 Oct;27(8):1098-102.

PMID:
17845538
6.

[A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin].

Kim YH, Han WS, Lee SJ, Oh SN, Choi DW, Byun KS, Yeon JE.

Korean J Hepatol. 2007 Sep;13(3):419-22. Korean.

PMID:
17898559
7.

Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.

Castera L, Constant A, Henry C, Champbenoit P, Bernard PH, De Ledinghen V, Demotes-Mainard J, Couzigou P.

Aliment Pharmacol Ther. 2006 Oct 15;24(8):1223-30.

8.

[A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].

Lee MY, Cho H, Kim YM, Lee JS.

Korean J Hepatol. 2006 Sep;12(3):444-8. Korean.

PMID:
16998297
9.
10.

Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin.

Cauli C, Serra G, Chessa L, Balestrieri C, Scioscia R, Lai ME, Farci P.

Haematologica. 2006 Jun;91(6 Suppl):ECR26.

11.

Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy.

Parise E, Cheinquer H, Crespo D, Meirelles A, Martinelli A, Sette H, Gallizi J, Silva R, Lacet C, Correa E, Cotrim H, Fonseca J, Paraná R, Spinelli V, Amorim W, Tatsch F, Pessoa M; Brazilian Pegasys Cooperative Study Group.

Braz J Infect Dis. 2006 Feb;10(1):11-6. Epub 2006 Jun 2.

PMID:
16767309
12.

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J.

N Engl J Med. 2002 Sep 26;347(13):975-82.

13.

[Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].

Halász T, Farkas A, Tolvaj G, Horváth G.

Orv Hetil. 2006 Feb 19;147(7):321-4. Hungarian.

PMID:
17489160
14.

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Schaefer M, Hinzpeter A, Mohmand A, Janssen G, Pich M, Schwaiger M, Sarkar R, Friebe A, Heinz A, Kluschke M, Ziemer M, Gutsche J, Weich V, Halangk J, Berg T.

Hepatology. 2007 Oct;46(4):991-8.

PMID:
17668880
15.

Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.

Antonini MG, Babudieri S, Maida I, Baiguera C, Zanini B, Fenu L, Dettori G, Manno D, Mura MS, Carosi G, Puoti M.

Infection. 2008 Jun;36(3):250-5. doi: 10.1007/s15010-007-7132-6. Epub 2008 May 3.

PMID:
18458815
16.

Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.

Demirturk N, Aykin N, Demirdal T, Cevik F.

Eur J Dermatol. 2006 Sep-Oct;16(5):579-80. No abstract available.

PMID:
17101483
17.

Managing the neuropsychiatric complications of hepatitis C treatment.

Sockalingam S, Shammi C, Stergiopoulos V.

Br J Hosp Med (Lond). 2007 Oct;68(10):520-5. Review.

PMID:
17974293
18.

Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.

Hoffman RG, Cohen MA, Alfonso CA, Weiss JJ, Jones S, Keller M, Condemarín JR, Chiu NM, Jacobson JM.

Psychosomatics. 2003 Sep-Oct;44(5):417-20. No abstract available.

PMID:
12954918
19.

Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection.

Adişen E, Dizbay M, Hizel K, Ilter N.

Indian J Dermatol Venereol Leprol. 2008 Jan-Feb;74(1):60-2. No abstract available.

20.

Supplemental Content

Support Center